Auto-Injectors Market

The global auto-injectors market is anticipated to grow at a considerable CAGR of 15% during the forecast period (2022-2028). The key companies operating in the industry are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships, mergers and acquisitions, geographical expansion, new product launches, and product innovation to remain competitive in the marketplace this is anticipated to positively impact significant market growth. For instance,

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/auto-injectors-market

•           In December 2021, Assertio Holdings, Inc., acquired Otrexup single dose once weekly auto-injector from Antares Pharma, Inc.

•           In November 2021, Gerresheimer acquired the IP of a new generation cartridge-based auto-injector of Midas Pharma. This new strategic partnership is for the development and marketing of the new generation auto-injector. 

•           In September 2021, Owen Mumford launched a new Aidaptus auto-injector platform which is single-use auto-injectors. This injector uses stopper sensing technology and it automatically adapts to the individual stopper. It is available in two different spring strengths to accommodate a variety of drug viscosities. 

•           In October 2019, Becton, Dickinson, and Company launched BD Intevia 1mL two-step disposable auto-injector that combines auto-injector and pre-fillable syringe in one integrated system.  It is a disposable autoinjector2-step push-on-skin device it enables the pharmaceutical industry to adopt it for a variety of drugs. 

•           In October 2019, AstraZeneca has received US Food and Drug Administration (FDA) approval for Fasenra (benralizumab), in a pre-filled, single-use auto-injector. This device is also approved in the European Union (EU) and currently it is an add-on maintenance treatment for severe eosinophilic asthma in the US, EU, Japan, and other countries

Market Coverage

•           The market number available for – 2021-2028

•           Base year- 2021

•           Forecast period- 2022-2028

•           Segment Covered- 

o          By Type

o          By Application

o          By End-User

•           Regions Covered-

o          North America

o          Europe

o          Asia-Pacific

o          Rest of the World

•           Competitive Landscape- AbbVie Inc., Amgen Inc., Johnson & Johnson Services, Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., Pfizer Inc., Ypsomed AG,  and others.

Key questions addressed by the report

•           What is the market growth rate?

•           Which segment and region dominate the market in the base year?

•           Which segment and region will project the fastest growth in the market?

•           How has COVID-19 impacted the market?

o          Deviation from the pre-COVID-19 forecast

o          Most affected region and segment

•           Who is the leader in the market?

•           How players are addressing challenges to sustain growth?

•           Where is the investment opportunity?

Global Auto-Injectors Market Report by Segment

By Type

• Disposable Autoinjectors
• Reusable Autoinjectors

By Applications

• Rheumatoid Arthritis
• Multiple Sclerosis
• Anaphylaxis
• Others (Cardiovascular Diseases, and Anemia)

By End User

• Home Care Settings
• Hospital & Clinics
• Others

A full report of Auto-Injectors Market is available at: https://www.omrglobal.com/industry-reports/auto-injectors-market

Global Auto-Injectors Market Report by Region

North America          

• United States
• Canada

Europe

• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific   

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Middle East & Africa
• Latin America

Company Profiles

• Antares Pharma, Inc.
• ApiJect Systems, Corp.
• AstraZeneca
• Bayer AG
• BD
• Biogen MA Inc.
• Frederick Furness Publishing Ltd. 
• Gerresheimer AG 
• Johnson & Johnson Services, Inc.
• Koch Industries, Inc. 
• Midas Pharma GmbH
• Novartis International AG
• Otsuka Holdings Co., Ltd. 
• Owen Mumford Ltd.

Reasons to Buying From us –

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Contact Person: Mr. Anurag Tiwari

Email: anurag@omrglobal.com

Contact no: +91 780-304-0404

Company Name: Orion Market Research

Article source: https://article-realm.com/article/Sports-Recreation/32719-Auto-Injectors-Market.html